International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Who Seeks Treatment for Dual Disorders? Observations from a Dual Disorder Clinic at the National Drug Dependence Treatment Centre in India Over a 12 Year Period

Yatan Pal Singh Balhara 1 , Siddharth Sarkar 1 , * , Sagar Chandra Bera 1 , Rishi Gupta 1 , Nishtha Chawla 1 and Rakesh Lal 1
Authors Information
1 Department of Psychiatry, National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India
Article information
  • International Journal of High Risk Behaviors and Addiction: March 2017, 6 (1); e32501
  • Published Online: September 26, 2016
  • Article Type: Research Article
  • Received: August 17, 2015
  • Accepted: January 23, 2016
  • DOI: 10.5812/ijhrba.32501

To Cite: Pal Singh Balhara Y, Sarkar S, Chandra Bera S, Gupta R, Chawla N, et al. Who Seeks Treatment for Dual Disorders? Observations from a Dual Disorder Clinic at the National Drug Dependence Treatment Centre in India Over a 12 Year Period, Int J High Risk Behav Addict. 2017 ; 6(1):e32501. doi: 10.5812/ijhrba.32501.

Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006; 67(2): 247-57[PubMed]
  • 2. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004; 61(8): 807-16[DOI][PubMed]
  • 3. Kessler RC. The epidemiology of dual diagnosis. Biol Psychiatry. 2004; 56(10): 730-7[DOI][PubMed]
  • 4. Basu D, Gupta N. Management of "dual diagnosis" patients : consensus, controversies and considerations. Indian J Psychiatry. 2000; 42(1): 34-47[PubMed]
  • 5. Morojele NK, Saban A, Seedat S. Clinical presentations and diagnostic issues in dual diagnosis disorders. Curr Opin Psychiatry. 2012; 25(3): 181-6[DOI][PubMed]
  • 6. Cridland EK, Deane FP, Hsu CI, Kelly PJ. A comparison of treatment outcomes for individuals with substance use disorder alone and individuals with probable dual diagnosis. Int J Ment Health Addict. 2012; 10(5): 670-83
  • 7. Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K, Kola L, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv. 2001; 52(4): 469-76[DOI][PubMed]
  • 8. Kelly TM, Daley DC, Douaihy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav. 2012; 37(1): 11-24[DOI][PubMed]
  • 9. Baigent M. Managing patients with dual diagnosis in psychiatric practice. Curr Opin Psychiatry. 2012; 25(3): 201-5[DOI][PubMed]
  • 10. Murthy P, Chand P. Treatment of dual diagnosis disorders. Curr Opin Psychiatry. 2012; 25(3): 194-200[DOI][PubMed]
  • 11. Sarkar S, Katana S, Mattoo SK. Managing dual diagnosis patients with psychosis and substance use disorders. J Ment Heal Hum Behav. 2012; 17: 25-38
  • 12. Basu D, Sarkar S, Mattoo SK. Psychiatric comorbidity in patients with substance use disorders attending an addiction treatment center in India over 11 years: Case for a specialized “dual diagnosis clinic”. J Dual Diagnos. 2013; 9(1): 23-9
  • 13. Mattoo SK, Singh SM, Sarkar S. De-addiction services in India. 2015;
  • 14. Ray R, Dhawan A, Chopra A. Addiction research centres and the nurturing of creativity: National Drug Dependence Treatment Centre, India--a profile. Addiction. 2013; 108(10): 1705-10[DOI][PubMed]
  • 15. Balhara YP, Jain R. A urinalysis-based study of buprenorphine and non-prescription opioid use among patients on buprenorphine maintenance. J Pharmacol Pharmacother. 2012; 3(1): 15-9[DOI][PubMed]
  • 16. Balhara YP, Jain R. Cannabis use among opioid-dependent individuals on opioid substitution therapy. J Pharmacol Pharmacother. 2014; 5(3): 203-5[DOI][PubMed]
  • 17. Nebhinani N, Sarkar S, Gupta S, Mattoo SK, Basu D. Demographic and clinical profile of substance abusing women seeking treatment at a de-addiction center in north India. Ind Psychiatry J. 2013; 22(1): 12-6[DOI][PubMed]
  • 18. Varshney M, Gupta R, Balhara YP. Yes, India has done it: Decriminalization of suicide in India. Asian J Psychiatr. 2015; 17: 103[DOI][PubMed]
  • 19. Balhara YP, Mishra A, Sethi H, Ray R. A retrospective chart review of treatment seeking middle aged individuals at a tertiary care substance use disorder treatment centre in North Part of India over five successive years: findings from drug abuse monitoring system. ScientificWorldJournal. 2013; 2013: 316372[DOI][PubMed]
  • 20. Kermode M, Songput CH, Sono CZ, Jamir TN, Devine A. Meeting the needs of women who use drugs and alcohol in North-east India - a challenge for HIV prevention services. BMC Public Health. 2012; 12: 825[DOI][PubMed]
  • 21. Murthy P, Manjunatha N, Subodh BN, Chand PK, Benegal V. Substance use and addiction research in India. Indian J Psychiatry. 2010; 52-99[DOI][PubMed]
  • 22. Sarkar S, Nebhinani N, Gupta S, Parakh P, Basu D. Pathways of progression from one substance use to another in treatment seekers. Drug Alcohol Depend. 2014; 140-6
  • 23. Jain R, Balhara YP, Jhanjee S, Sethi H. Concordance between urinary cotinine levels and self-reported tobacco use among drug-dependent persons: a pilot study. Subst Abus. 2012; 33(2): 99-102[DOI][PubMed]
  • 24. Quraishi R, Jain R, Balhara YP. Profile of nicotine use among alcohol dependent patients visiting a tertiary care center in north India. Indian J Psychol Med. 2014; 36(2): 174-8[DOI][PubMed]
  • 25. Aggarwal M, Banerjee A, Singh SM, Mattoo SK, Basu D. Substance-induced psychotic disorders: 13-year data from a de-addiction centre and their clinical implications. Asian J Psychiatr. 2012; 5(3): 220-4[DOI][PubMed]
  • 26. Parakh P, Basu D. Cannabis and psychosis: have we found the missing links? Asian J Psychiatr. 2013; 6(4): 281-7[DOI][PubMed]
  • 27. Gibbs M, Winsper C, Marwaha S, Gilbert E, Broome M, Singh SP. Cannabis use and mania symptoms: a systematic review and meta-analysis. J Affect Disord. 2015; 171: 39-47[DOI][PubMed]
  • 28. Schuckit MA. Alcohol and depression: a clinical perspective. Acta Psychiatrica Scandinavica. 1994; 89: 28-32
  • 29. Damjanovic A, Pantovic M, Damjanovic A, Dunjic-Kostic B, Ivkovic M, Milovanovic S, et al. Cannabis and psychosis revisited. Psychiatria Danubina. 2015; 27(1)-100
  • 30. Degenhardt L, Hall W. Cannabis and psychosis. Curr Psychiatry Rep. 2002; 4(3): 191-6[PubMed]
  • 31. Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997; 4(5): 231-44[DOI][PubMed]
  • 32. Mueser KT, Drake RE, Wallach MA. Dual diagnosis: a review of etiological theories. Addict Behav. 1998; 23(6): 717-34[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments